BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wood ME, Vogel V, Ng A, Foxhall L, Goodwin P, Travis LB. Second malignant neoplasms: assessment and strategies for risk reduction. J Clin Oncol. 2012;30:3734-3745. [PMID: 23008293 DOI: 10.1200/jco.2012.41.8681] [Cited by in Crossref: 152] [Cited by in F6Publishing: 93] [Article Influence: 15.2] [Reference Citation Analysis]
Number Citing Articles
1 Luskin MR, Banerjee R, Del Percio S, Loren AW. A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies. Curr Hematol Malig Rep 2015;10:225-36. [PMID: 26162948 DOI: 10.1007/s11899-015-0274-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Hatzoglou V, Tisnado J, Mehta A, Peck KK, Daras M, Omuro AM, Beal K, Holodny AI. Dynamic contrast-enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases. Cancer Med 2017;6:761-7. [PMID: 28303695 DOI: 10.1002/cam4.1046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
3 Hardardottir H, Aspelund T, Zhu J, Fall K, Hauksdottir A, Fang F, Lu D, Janson C, Jonsson S, Valdimarsdottir H, Valdimarsdottir UA. Optimal communication associated with lower risk of acute traumatic stress after lung cancer diagnosis. Support Care Cancer 2021. [PMID: 34273032 DOI: 10.1007/s00520-021-06138-4] [Reference Citation Analysis]
4 Voce DJ, Schmitt AM, Uppal A, McNerney ME, Bernal GM, Cahill KE, Wahlstrom JS, Nassiri A, Yu X, Crawley CD, White KP, Onel K, Weichselbaum RR, Yamini B. Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor. Oncogene 2015;34:2807-13. [PMID: 25043302 DOI: 10.1038/onc.2014.211] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
5 Nekhlyudov L, Aziz NM, Lerro C, Virgo KS. Oncologists' and primary care physicians' awareness of late and long-term effects of chemotherapy: implications for care of the growing population of survivors. J Oncol Pract 2014;10:e29-36. [PMID: 24222054 DOI: 10.1200/JOP.2013.001121] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
6 Batsivari A, Haltalli MLR, Passaro D, Pospori C, Lo Celso C, Bonnet D. Dynamic responses of the haematopoietic stem cell niche to diverse stresses. Nat Cell Biol 2020;22:7-17. [PMID: 31907409 DOI: 10.1038/s41556-019-0444-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 20.0] [Reference Citation Analysis]
7 Nakajima T, Vares G, Wang B, Nenoi M. Chronic Intake of Japanese Sake Mediates Radiation-Induced Metabolic Alterations in Mouse Liver. PLoS One 2016;11:e0146730. [PMID: 26752639 DOI: 10.1371/journal.pone.0146730] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
8 Reed SC, Bell JF, Miglioretti DL, Nekhlyudov L, Fairman N, Joseph JG. Relationships Between Fear of Cancer Recurrence and Lifestyle Factors Among Cancer Survivors. J Canc Educ 2020;35:669-77. [DOI: 10.1007/s13187-019-01509-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Koller PB, Kantarjian HM, Nogueras-Gonzalez GM, Jabbour E, Verstovsek S, Borthakur G, Estrov Z, Wierda WG, Garcia-Manero G, Ferrajoli A, Ravandi F, O'Brien SM, Cortes JE. Chronic myeloid leukemia among patients with a history of prior malignancies: A tale of dual survivorship. Cancer 2017;123:609-16. [PMID: 27763690 DOI: 10.1002/cncr.30362] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Tsui K, Gajjar A, Li C, Srivastava D, Broniscer A, Wetmore C, Kun LE, Merchant TE, Ellison DW, Orr BA, Boop FA, Klimo P, Ross J, Robison LL, Armstrong GT. Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapy. Neuro Oncol 2015;17:448-56. [PMID: 25395462 DOI: 10.1093/neuonc/nou279] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
11 Teboul L, Herault Y, Wells S, Qasim W, Pavlovic G. Variability in Genome Editing Outcomes: Challenges for Research Reproducibility and Clinical Safety. Mol Ther 2020;28:1422-31. [PMID: 32243835 DOI: 10.1016/j.ymthe.2020.03.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
12 Chattopadhyay S, Zheng G, Hemminki O, Försti A, Sundquist K, Hemminki K. Prostate cancer survivors: Risk and mortality in second primary cancers. Cancer Med 2018;7:5752-9. [PMID: 30277023 DOI: 10.1002/cam4.1764] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
13 Hoeller U, Borgmann K, Oertel M, Haverkamp U, Budach V, Eich HT. Late Sequelae of Radiotherapy. Dtsch Arztebl Int 2021;118:205-11. [PMID: 34024324 DOI: 10.3238/arztebl.m2021.0024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
14 Shin DW, Choi YJ, Kim HS, Han KD, Yoon H, Park YS, Kim N, Lee DH. Secondary Breast, Ovarian, and Uterine Cancers After Colorectal Cancer: A Nationwide Population-Based Cohort Study in Korea. Dis Colon Rectum 2018;61:1250-7. [PMID: 30239394 DOI: 10.1097/DCR.0000000000001203] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
15 Zang Y, Qi F, Cheng Y, Xia T, Xiao R, Li X, Yang N. Survival outcomes in prostate cancer patients with a prior cancer. Transl Androl Urol 2021;10:741-53. [PMID: 33718076 DOI: 10.21037/tau-20-897] [Reference Citation Analysis]
16 Nekhlyudov L, Mollica MA, Jacobsen PB, Mayer DK, Shulman LN, Geiger AM. Developing a Quality of Cancer Survivorship Care Framework: Implications for Clinical Care, Research, and Policy. J Natl Cancer Inst 2019;111:1120-30. [PMID: 31095326 DOI: 10.1093/jnci/djz089] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 30.5] [Reference Citation Analysis]
17 O'Reilly M, Keane F, Mc Dermott R. Synchronous Melanoma and Pancreas Malignancies Leading to a Discovery of a CDKN2A Mutation in a Patient with No Known Family History. Case Rep Oncol 2021;14:333-7. [PMID: 33776725 DOI: 10.1159/000512999] [Reference Citation Analysis]
18 Kim S, Bang JI, Boo D, Kim B, Choi IY, Ko S, Yoo IR, Kim K, Kim J, Joo Y, Ryoo HG, Paeng JC, Park JM, Jang W, Kim B, Chung Y, Yang D, Yoo S, Lee HY. Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics. Eur J Nucl Med Mol Imaging 2022. [PMID: 35362796 DOI: 10.1007/s00259-022-05779-9] [Reference Citation Analysis]
19 Guan X, Wei R, Yang R, Lu Z, Liu E, Zhao Z, Chen H, Yang M, Liu Z, Jiang Z, Wang X. Association of Radiotherapy for Rectal Cancer and Second Gynecological Malignant Neoplasms. JAMA Netw Open 2021;4:e2031661. [PMID: 33416884 DOI: 10.1001/jamanetworkopen.2020.31661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ye Y, Neil AL, Wills KE, Venn AJ. Temporal trends in the risk of developing multiple primary cancers: a systematic review. BMC Cancer 2016;16:849. [PMID: 27814758 DOI: 10.1186/s12885-016-2876-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
21 Zhang R, Mirkovic D, Newhauser WD. Visualization of risk of radiogenic second cancer in the organs and tissues of the human body. Radiat Oncol 2015;10:107. [PMID: 25927490 DOI: 10.1186/s13014-015-0404-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
22 Jégu J, Colonna M, Daubisse-Marliac L, Trétarre B, Ganry O, Guizard AV, Bara S, Troussard X, Bouvier V, Woronoff AS, Velten M. The effect of patient characteristics on second primary cancer risk in France. BMC Cancer 2014;14:94. [PMID: 24528929 DOI: 10.1186/1471-2407-14-94] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
23 Boucher AA, Blaes AH. Prophylactic mastectomy: a treatment alternative for Hodgkin survivors? Clin Breast Cancer 2013;13:307-8. [PMID: 23891588 DOI: 10.1016/j.clbc.2013.06.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
24 Kanguru L, Bikker A, Cavers D, Barnett K, Brewster DH, Weller D, Campbell C. Pathways to diagnosis of a second primary cancer: protocol for a mixed-methods systematic review. BMJ Open 2017;7:e017929. [PMID: 29273656 DOI: 10.1136/bmjopen-2017-017929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
25 Habash M, Bohorquez LC, Kyriakou E, Kron T, Martin OA, Blyth BJ. Clinical and Functional Assays of Radiosensitivity and Radiation-Induced Second Cancer. Cancers (Basel) 2017;9:E147. [PMID: 29077012 DOI: 10.3390/cancers9110147] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 5.2] [Reference Citation Analysis]
26 El-Saghire H, Vandevoorde C, Ost P, Monsieurs P, Michaux A, De Meerleer G, Baatout S, Thierens H. Intensity modulated radiotherapy induces pro-inflammatory and pro-survival responses in prostate cancer patients. Int J Oncol 2014;44:1073-83. [PMID: 24435511 DOI: 10.3892/ijo.2014.2260] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
27 Park SM, Yun YH, Kim YA, Jo M, Won YJ, Back JH, Lee ES. Prediagnosis Body Mass Index and Risk of Secondary Primary Cancer in Male Cancer Survivors: A Large Cohort Study. J Clin Oncol 2016;34:4116-24. [PMID: 27863195 DOI: 10.1200/JCO.2016.66.4920] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
28 Zheng G, Sundquist K, Sundquist J, Chen T, Försti A, Hemminki O, Hemminki K. Second Primary Cancers After Kidney Cancers, and Kidney Cancers as Second Primary Cancers. Eur Urol Open Sci 2021;24:52-9. [PMID: 34337496 DOI: 10.1016/j.euros.2020.12.007] [Reference Citation Analysis]
29 Andersen BL, DeRubeis RJ, Berman BS, Gruman J, Champion VL, Massie MJ, Holland JC, Partridge AH, Bak K, Somerfield MR, Rowland JH; American Society of Clinical Oncology. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol 2014;32:1605-19. [PMID: 24733793 DOI: 10.1200/JCO.2013.52.4611] [Cited by in Crossref: 345] [Cited by in F6Publishing: 141] [Article Influence: 43.1] [Reference Citation Analysis]
30 Dayer N, Fasquelle F, Salati E, Dietrich G. Multiple primary malignancies: synchronous lymphoma, pancreatic neuroendocrine tumour and colorectal cancer. BMJ Case Rep 2021;14:e241938. [PMID: 34088689 DOI: 10.1136/bcr-2021-241938] [Reference Citation Analysis]
31 Sakellakis M, Peroukides S, Iconomou G, Boumpoucheropoulos S, Kalofonos H. Multiple primary malignancies: a report of two cases. Chin J Cancer Res 2014;26:215-8. [PMID: 24826064 DOI: 10.3978/j.issn.1000-9604.2014.02.15] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
32 Jin F, Luo HL, Zhou J, He YN, Liu XF, Zhong MS, Yang H, Li C, Li QC, Huang X, Tian XM, Qiu D, He GL, Yin L, Wang Y. Cancer risk assessment in modern radiotherapy workflow with medical big data. Cancer Manag Res 2018;10:1665-75. [PMID: 29970965 DOI: 10.2147/CMAR.S164980] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
33 Liang F, Zhang S, Xue H, Chen Q. Risk of second primary cancers in cancer patients treated with cisplatin: a systematic review and meta-analysis of randomized studies. BMC Cancer 2017;17:871. [PMID: 29258467 DOI: 10.1186/s12885-017-3902-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
34 Travis LB, Demark Wahnefried W, Allan JM, Wood ME, Ng AK. Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol 2013;10:289-301. [PMID: 23529000 DOI: 10.1038/nrclinonc.2013.41] [Cited by in Crossref: 136] [Cited by in F6Publishing: 130] [Article Influence: 15.1] [Reference Citation Analysis]
35 Townsend JS, Sitaker M, Rose JM, Rohan EA, Gardner A, Moore AR. Capacity Building for and Implementation of Policy, Systems, and Environmental Change: Results from a Survey of the National Comprehensive Cancer Control Program. Popul Health Manag 2019;22:330-8. [PMID: 30332328 DOI: 10.1089/pop.2018.0082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Broly E, Barthélémy P, Ciftci S, Borel C, Broly M, Gros CI, Marcellin L, Bornert F. Hidden intra-mandibular carcinoma cuniculatum appearing in a patient with metastatic prostate cancer: a case report. BMC Oral Health 2019;19:54. [PMID: 30953484 DOI: 10.1186/s12903-019-0745-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, Friedman DL, Goldman M, Jones L, King A, Kvale E, Langbaum TS, Ligibel JA, McCabe MS, McVary KT, Melisko M, Montoya JG, Mooney K, Morgan MA, O'Connor T, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D. Survivorship: introduction and definition. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2014;12:34-45. [PMID: 24453291 DOI: 10.6004/jnccn.2014.0005] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 7.6] [Reference Citation Analysis]
38 Zheng X, Li X, Wang M, Shen J, Sisti G, He Z, Huang J, Li YM, Wu A; Multidisciplinary Oncology Research Collaborative Group (MORCG). Second primary malignancies among cancer patients. Ann Transl Med 2020;8:638. [PMID: 32566575 DOI: 10.21037/atm-20-2059] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Denlinger CS, Sanft T, Moslehi JJ, Overholser L, Armenian S, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Henry NL, Hill-Kayser C, Hudson M, Khakpour N, Koura D, McDonough AL, Melisko M, Mooney K, Moore HCF, Moryl N, O'Connor T, Paskett ED, Patel C, Peterson L, Pirl W, Rodriguez MA, Ruddy KJ, Shockney L, Smith S, Syrjala KL, Tevaarwerk A, Zee P, McMillian NR, Freedman-Cass DA. NCCN Guidelines Insights: Survivorship, Version 2.2020. J Natl Compr Canc Netw 2020;18:1016-23. [PMID: 32755975 DOI: 10.6004/jnccn.2020.0037] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
40 Finkelstein DM, Horick NK, Ramchandani R, Boyd KL, Rana HQ, Bychkovsky BL. Are rare cancer survivors at elevated risk of subsequent new cancers? BMC Cancer 2019;19:166. [PMID: 30791872 DOI: 10.1186/s12885-019-5358-1] [Reference Citation Analysis]
41 Deng L, Harðardottír H, Song H, Xiao Z, Jiang C, Wang Q, Valdimarsdóttir U, Cheng H, Loo BW, Lu D. Mortality of lung cancer as a second primary malignancy: A population-based cohort study. Cancer Med 2019;8:3269-77. [PMID: 30993899 DOI: 10.1002/cam4.2172] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
42 Joung JY, Kwon WA, Lim J, Oh CM, Jung KW, Kim SH, Seo HK, Park WS, Chung J, Lee KH, Won YJ. Second Primary Cancer Risk among Kidney Cancer Patients in Korea: A Population-Based Cohort Study. Cancer Res Treat 2018;50:293-301. [PMID: 28421722 DOI: 10.4143/crt.2016.543] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
43 Li D, Weng S, Zhong C, Tang X, Zhu N, Cheng Y, Xu D, Yuan Y. Risk of Second Primary Cancers Among Long-Term Survivors of Breast Cancer. Front Oncol 2019;9:1426. [PMID: 31998630 DOI: 10.3389/fonc.2019.01426] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
44 Lee YT, Liu CJ, Hu YW, Teng CJ, Tzeng CH, Yeh CM, Chen TJ, Lin JK, Lin CC, Lan YT. Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based Cohort of 98,876 Patients in Taiwan. Medicine (Baltimore). 2015;94:e1079. [PMID: 26131831 DOI: 10.1097/md.0000000000001079] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
45 Zhang R, Howell RM, Taddei PJ, Giebeler A, Mahajan A, Newhauser WD. A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation. Radiother Oncol 2014;113:84-8. [PMID: 25128084 DOI: 10.1016/j.radonc.2014.07.003] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
46 Wang Z, Yin Y, Wang J, Zhu Y, Li X, Zeng X. Standardized Incidence Rate, Risk and Survival Outcomes of Second Primary Malignancy Among Renal Cell Carcinoma Survivors: A Nested Case-Control Study. Front Oncol 2021;11:716741. [PMID: 34395291 DOI: 10.3389/fonc.2021.716741] [Reference Citation Analysis]
47 Yu X, Song X, Zhu L, Chen W, Dai D, Li X, Xu W. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Newly Found Suspected Malignant Solitary Pulmonary Lesions in Patients Who Have Received Curative Treatment for Colorectal Cancer. Gastroenterol Res Pract 2017;2017:3458739. [PMID: 28487728 DOI: 10.1155/2017/3458739] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
48 Yang L, Xiong Z, Xie QK, He W, Liu S, Kong P, Jiang C, Xia X, Xia L. Second primary colorectal cancer after the initial primary colorectal cancer. BMC Cancer 2018;18:931. [PMID: 30261873 DOI: 10.1186/s12885-018-4823-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
49 Timoshkina NN, Gvaldin DY, Omelchuk EP, Vashhenko LN, Ausheva TV, Kechedzhieva EE, Kit OI. A clinical case of multiple primary cancers in a carrier of rare SDK2 and NOTCH2 gene mutations. Egypt J Med Hum Genet 2021;22. [DOI: 10.1186/s43042-021-00176-7] [Reference Citation Analysis]
50 Raciborska A, Bilska K, Koziński T, Rodriguez-galindo C. Subsequent Malignant Neoplasm of Bone in Children and Adolescent—Possibility of Multimodal Treatment. Current Oncology 2022;29:1001-7. [DOI: 10.3390/curroncol29020085] [Reference Citation Analysis]
51 Chattopadhyay S, Yu H, Sud A, Sundquist J, Försti A, Hemminki A, Hemminki K. Multiple myeloma: family history and mortality in second primary cancers. Blood Cancer J 2018;8:75. [PMID: 30087319 DOI: 10.1038/s41408-018-0108-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
52 Williamson CW, Paravati A, Ghassemi M, Lethert K, Hua P, Hartman P, Sanghvi P. Five Simultaneous Primary Tumors in a Single Patient: A Case Report and Review of the Literature. Case Rep Oncol 2015;8:432-8. [PMID: 26600775 DOI: 10.1159/000440799] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
53 Morton LM, Kerns SL, Dolan ME. Role of Germline Genetics in Identifying Survivors at Risk for Adverse Effects of Cancer Treatment. Am Soc Clin Oncol Educ Book 2018;38:775-86. [PMID: 30231410 DOI: 10.1200/EDBK_201391] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
54 Lee C, Jeong BH, Lee K, Zo JI, Sun JM, Choi YL, Kim H. Second primary pleomorphic carcinoma arising from the pneumonectomy cavity of non-small cell lung cancer: A case report. Respir Med Case Rep 2021;32:101373. [PMID: 33732613 DOI: 10.1016/j.rmcr.2021.101373] [Reference Citation Analysis]
55 Cavers D, Duff R, Bikker A, Barnett K, Kanguru L, Weller D, Brewster DH, Campbell C. Patient and GP experiences of pathways to diagnosis of a second primary cancer: a qualitative study. BMC Cancer 2021;21:496. [PMID: 33941114 DOI: 10.1186/s12885-021-08238-0] [Reference Citation Analysis]
56 Medina HN, Schlumbrecht MP, Penedo FJ, Pinheiro PS. Survival for endometrial cancer as a second primary malignancy. Cancer Med 2022. [PMID: 35098701 DOI: 10.1002/cam4.4554] [Reference Citation Analysis]
57 McKeague M. Aptamers for DNA Damage and Repair. Int J Mol Sci 2017;18:E2212. [PMID: 29065503 DOI: 10.3390/ijms18102212] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
58 Zaid M, Elganainy D, Dogra P, Dai A, Widmann L, Fernandes P, Wang Z, Pelaez MJ, Ramirez JR, Singhi AD, Dasyam AK, Brand RE, Park WG, Rahmanuddin S, Rosenthal MH, Wolpin BM, Khalaf N, Goel A, Von Hoff DD, Tamm EP, Maitra A, Cristini V, Koay EJ. Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Early Detection. Front Oncol 2020;10:596931. [PMID: 33344245 DOI: 10.3389/fonc.2020.596931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Wu Y, Chen X, Qian D, Wang W, Zhang Y, Hu J, Zhu J, Wu Q, Cao T. Effect of prior cancer on survival outcomes for patients with advanced prostate cancer. BMC Urol 2021;21:26. [PMID: 33596896 DOI: 10.1186/s12894-021-00792-w] [Reference Citation Analysis]
60 White MC, Hayes NS, Richardson LC. Public Health's Future Role in Cancer Survivorship. Am J Prev Med 2015;49:S550-3. [PMID: 26590651 DOI: 10.1016/j.amepre.2015.08.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
61 Tarrab R, Sabouni R, Jarad L, Mansour N, Saifo MS. Metachronous breast cancer in a male with previous history of liposarcoma: A case report from Syria. Ann Med Surg (Lond) 2021;72:103151. [PMID: 34934489 DOI: 10.1016/j.amsu.2021.103151] [Reference Citation Analysis]
62 Seike Y, Kawagishi Y, Bando A, Kimoto K, Hongo M, Takeda S. Development of second primary small-cell lung cancer within the irradiated field after chemoradiotherapy: a report of two cases. Respirol Case Rep 2021;9:e00767. [PMID: 34094568 DOI: 10.1002/rcr2.767] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Savage P. Chemotherapy curable malignancies and cancer stem cells: A biological review and hypothesis. BMC Cancer. 2016;16:906. [PMID: 27871274 DOI: 10.1186/s12885-016-2956-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
64 Zheng G, Hemminki A, Försti A, Sundquist J, Sundquist K, Hemminki K. Second primary cancer after female breast cancer: Familial risks and cause of death. Cancer Med 2019;8:400-7. [PMID: 30479046 DOI: 10.1002/cam4.1899] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
65 Stan D, Loprinzi CL, Ruddy KJ. Breast cancer survivorship issues. Hematol Oncol Clin North Am 2013;27:805-27, ix. [PMID: 23915746 DOI: 10.1016/j.hoc.2013.05.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
66 Zhang Z, Liu F, Qu Y, Qiu L, Zhang L, Yang Q. Second primary malignancy among malignant solid tumor survivors aged 85 years and older. Sci Rep 2021;11:19748. [PMID: 34611235 DOI: 10.1038/s41598-021-99260-6] [Reference Citation Analysis]
67 Nagel ZD, Kitange GJ, Gupta SK, Joughin BA, Chaim IA, Mazzucato P, Lauffenburger DA, Sarkaria JN, Samson LD. DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma Multiforme. Cancer Res 2017;77:198-206. [PMID: 27793847 DOI: 10.1158/0008-5472.CAN-16-1151] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 9.7] [Reference Citation Analysis]
68 Kwon WA, Joung JY, Lim J, Oh CM, Jung KW, Kim SH, Seo HK, Park WS, Chung J, Lee KH, Won YJ. Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea. BMC Cancer 2018;18:617. [PMID: 29855390 DOI: 10.1186/s12885-018-4530-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
69 Inui K, Nakagawa Y, Hasegawa G, Ikeda Y, Sato Y, Nishiyama T, Tomita Y. Urothelial carcinoma with sarcomatous variant of the bladder following radiotherapy for cervical cancer: A case report. Urol Case Rep 2018;17:125-7. [PMID: 29487801 DOI: 10.1016/j.eucr.2018.01.025] [Reference Citation Analysis]
70 Ji F, Yang CQ, Li XL, Zhang LL, Yang M, Li JQ, Gao HF, Zhu T, Cheng MY, Li WP, Wu SY, Zhong AL, Wang K. Risk of breast cancer-related death in women with a prior cancer. Aging (Albany NY) 2020;12:5894-906. [PMID: 32250967 DOI: 10.18632/aging.102984] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
71 Romanelli K, Wells J, Patel A, Mendonca Torres M, Costello J, Jensen K, Vasko V. Clinical and molecular characterization of thyroid cancer when seen as a second malignant neoplasm. Therapeutic Advances in Endocrinology 2021;12:204201882110583. [DOI: 10.1177/20420188211058327] [Reference Citation Analysis]
72 Chao C, Bhatia S, Xu L, Cannavale KL, Wong FL, Huang PS, Cooper R, Armenian SH. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer. JAMA Netw Open 2019;2:e195536. [PMID: 31173129 DOI: 10.1001/jamanetworkopen.2019.5536] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
73 Jorgensen ML, Young JM, Solomon MJ. Optimal delivery of colorectal cancer follow-up care: improving patient outcomes. Patient Relat Outcome Meas 2015;6:127-38. [PMID: 26056501 DOI: 10.2147/PROM.S49589] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
74 Deng W, Wang Y, Liu X, Liu J, Wang L, Yang Z, Yang M, An Y, Tang C, Sanford NN, Kim BYS, Jiang W. Assessment of Trends in Second Primary Cancers in Patients With Metastatic Melanoma From 2005 to 2016. JAMA Netw Open 2020;3:e2028627. [PMID: 33295975 DOI: 10.1001/jamanetworkopen.2020.28627] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
75 Wang TH, Liu CJ, Chao TF, Chen TJ, Hu YW. Second primary malignancy risk after radiotherapy in rectal cancer survivors. World J Gastroenterol 2018; 24(40): 4586-4595 [PMID: 30386108 DOI: 10.3748/wjg.v24.i40.4586] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
76 He C, Zhang Y, Cai Z, Lin X. Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: a propensity score analysis. BMC Cancer 2019;19:509. [PMID: 31142278 DOI: 10.1186/s12885-019-5744-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
77 Mehnert-Theuerkauf A, Esser P. [Survivorship care plans for cancer patients: the importance of risk stratification, self-management and health literacy in the age of digital care]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2022. [PMID: 35275217 DOI: 10.1007/s00103-022-03514-1] [Reference Citation Analysis]
78 Wood ME, Kadlubek P, Pham TH, Wollins DS, Lu KH, Weitzel JN, Neuss MN, Hughes KS. Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative. J Clin Oncol 2014;32:824-9. [PMID: 24493722 DOI: 10.1200/JCO.2013.51.4661] [Cited by in Crossref: 104] [Cited by in F6Publishing: 55] [Article Influence: 13.0] [Reference Citation Analysis]
79 Wu Y, Li Y, Han C, Chong Y, Kang K, Liu Z, Zhang F. Risk of second primary malignancies associated with radiotherapy in prostate cancer patients: competing risk analysis. Future Oncol 2022. [PMID: 35018785 DOI: 10.2217/fon-2021-0332] [Reference Citation Analysis]
80 Zheng G, Chattopadhyay S, Försti A, Sundquist K, Hemminki K. Familial risks of second primary cancers and mortality in ovarian cancer patients. Clin Epidemiol 2018;10:1457-66. [PMID: 30349393 DOI: 10.2147/CLEP.S174173] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
81 Sato A, Matsubayashi K, Morishima T, Nakata K, Kawakami K, Miyashiro I. Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: a population-based study. BMC Cancer 2021;21:264. [PMID: 33691661 DOI: 10.1186/s12885-021-08011-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 AlBaqmi KH, AlMudaiheem FA, Boghdadly S, AlHussaini KA, Shokor N, AlOudah N. Multiple Primary Malignancies of the Colon, Stomach, and Kidney in a Patient with Bowel Obstruction Requiring Emergency Surgery: A Case Report. Am J Case Rep 2020;21:e926472. [PMID: 33243966 DOI: 10.12659/AJCR.926472] [Reference Citation Analysis]
83 Milano MT, Dinh PC, Yang H, Zaid MA, Fossa SD, Feldman DR, Monahan PO, Travis LB, Fung C. Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24 900 Survivors. JNCI Cancer Spectr 2020;4:pkaa017. [PMID: 32455335 DOI: 10.1093/jncics/pkaa017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Tang Z, Zou X, Luo Q, Wang Y, Jin F. The Risk of Radiogenic Second Cancer Based on Differential DVH: Central Nervous System Malignant Tumor in Children. Technol Cancer Res Treat 2019;18:1533033819886899. [PMID: 31707971 DOI: 10.1177/1533033819886899] [Reference Citation Analysis]
85 Huang L, Meng C, Liu D, Fu XJ. Secondary peripheral T-cell lymphoma and acute myeloid leukemia after Burkitt lymphoma treatment: A case report. World J Clin Cases 2021; 9(24): 7237-7244 [PMID: 34540984 DOI: 10.12998/wjcc.v9.i24.7237] [Reference Citation Analysis]
86 Bang JI, Lee ES, Kim TS, Kim SK. Unexpected Second Primary Malignancies Detected by F-18 FDG PET/CT During Follow-up for Primary Malignancy: Two Case Reports. Nucl Med Mol Imaging 2015;49:65-8. [PMID: 25767625 DOI: 10.1007/s13139-014-0302-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
87 Morais S, Antunes L, Bento MJ, Lunet N. The contribution of second primary cancers to the mortality of patients with a gastric first primary cancer. Eur J Gastroenterol Hepatol 2019;31:471-7. [PMID: 30601339 DOI: 10.1097/MEG.0000000000001348] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
88 Manthri S, Geraci SA, Chakraborty K. Overview of Cancer Survivorship Care for Primary Care Providers. Cureus 2020;12:e10210. [PMID: 33033685 DOI: 10.7759/cureus.10210] [Reference Citation Analysis]
89 Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB. Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study. J Clin Oncol 2013;31:3807-14. [PMID: 24043737 DOI: 10.1200/JCO.2013.50.3409] [Cited by in Crossref: 92] [Cited by in F6Publishing: 27] [Article Influence: 10.2] [Reference Citation Analysis]
90 van Gerwen M, Maggen C, Cardonick E, Verwaaijen EJ, van den Heuvel-Eibrink M, Shmakov RG, Boere I, Gziri MM, Ottevanger PB, Lok CAR, Halaska M, Shao LT, Struys I, van Dijk-Lokkart EM, Van Calsteren K, Fruscio R, Zola P, Scarfone G, Amant F; International Network on Cancer, Infertility and Pregnancy. Association of Chemotherapy Timing in Pregnancy With Congenital Malformation. JAMA Netw Open 2021;4:e2113180. [PMID: 34106263 DOI: 10.1001/jamanetworkopen.2021.13180] [Reference Citation Analysis]
91 Colonna S, Curtin K, Johnson E, Kohlmann W, Wright J, Kirchhoff A, Tavtigian S, Schiffman J. Family History of Breast Cancer Associated with Breast Cancer in Survivors of Hodgkin Lymphoma. Int J Cancer Clin Res 2019;6:107. [PMID: 30976660 DOI: 10.23937/2378-3419/1410107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
92 Jabson JM, Farmer GW, Bowen DJ. Health Behaviors and Self-Reported Health Among Cancer Survivors by Sexual Orientation. LGBT Health 2015;2:41-7. [PMID: 26790017 DOI: 10.1089/lgbt.2014.0038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
93 Halamkova J, Kazda T, Pehalova L, Gonec R, Kozakova S, Bohovicova L, Krakorova DA, Slaby O, Demlova R, Svoboda M, Kiss I. Second primary malignancies in colorectal cancer patients. Sci Rep 2021;11:2759. [PMID: 33531585 DOI: 10.1038/s41598-021-82248-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Mujcic A, Blankers M, Boon B, Engels R, van Laar M. Internet-based self-help smoking cessation and alcohol moderation interventions for cancer survivors: a study protocol of two RCTs. BMC Cancer 2018;18:364. [PMID: 29609554 DOI: 10.1186/s12885-018-4206-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
95 Hendlisz A, Golfinopoulos V, Deleporte A, Paesmans M, Mansy HE, Garcia C, Peeters M, Annemans L, Vandeputte C, Maetens M, Borbath I, Dresse D, Houbiers G, Fried M, Awada A, Piccart M, Laethem JL, Flamen P. Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study. BMC Cancer 2013;13:190. [PMID: 23587148 DOI: 10.1186/1471-2407-13-190] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
96 Jung SY, Kim YA, Jo M, Park SM, Won YJ, Ghang H, Kong SY, Jung KW, Lee ES. Prediagnosis obesity and secondary primary cancer risk in female cancer survivors: A national cohort study. Cancer Med 2019;8:824-38. [PMID: 30652416 DOI: 10.1002/cam4.1959] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
97 Halamkova J, Kazda T, Pehalova L, Gonec R, Kozakova S, Bohovicova L, Slaby O, Demlova R, Svoboda M, Kiss I. The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients. Front Oncol 2020;10:573394. [PMID: 33585194 DOI: 10.3389/fonc.2020.573394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Vogt A, Schmid S, Heinimann K, Frick H, Herrmann C, Cerny T, Omlin A. Multiple primary tumours: challenges and approaches, a review. ESMO Open. 2017;2:e000172. [PMID: 28761745 DOI: 10.1136/esmoopen-2017-000172] [Cited by in Crossref: 109] [Cited by in F6Publishing: 101] [Article Influence: 21.8] [Reference Citation Analysis]
99 Harvey A, Zhang Y, Phillips S, Suarez R, Dekle L, Villalobos A, Pratt-Chapman ML. Initial Outcomes of an Online Continuing Education Series Focused on Post-treatment Cancer Survivorship Care. J Cancer Educ 2020;35:144-50. [PMID: 30488369 DOI: 10.1007/s13187-018-1453-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Khoiwal K, Gaurav A, Tiwari S, Chaturvedi J, Singh A. Synchronous Primary Malignancy of Female Genital Tract: A Report of Two Cases and Review of Literature. J Midlife Health 2019;10:51-4. [PMID: 31001059 DOI: 10.4103/jmh.JMH_138_18] [Reference Citation Analysis]
101 Fung C, Dinh P Jr, Ardeshir-Rouhani-Fard S, Schaffer K, Fossa SD, Travis LB. Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors. Adv Urol. 2018;2018:8671832. [PMID: 29670654 DOI: 10.1155/2018/8671832] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 11.0] [Reference Citation Analysis]
102 Parekh JD, Kukrety S, Thandra A, Valenta C. Multiple Primary Malignant Neoplasms in an Elderly Patient. Cureus 2018;10:e2384. [PMID: 29850379 DOI: 10.7759/cureus.2384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
103 Chaim IA, Nagel ZD, Jordan JJ, Mazzucato P, Ngo LP, Samson LD. In vivo measurements of interindividual differences in DNA glycosylases and APE1 activities. Proc Natl Acad Sci U S A 2017;114:E10379-88. [PMID: 29122935 DOI: 10.1073/pnas.1712032114] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
104 Savage P. Clinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential. BMC Cancer 2015;15:11. [PMID: 25605631 DOI: 10.1186/s12885-015-1006-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
105 Zhu K, Lin R, Zhang Z, Chen H, Rao X. Impact of prior cancer history on the survival of patients with larynx cancer. BMC Cancer 2020;20:1137. [PMID: 33228622 DOI: 10.1186/s12885-020-07634-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]